Latest Pest Control News

Page 1 of 2
Bio-Gene has signed a term sheet with Sumitomo Corporation and Nakashima Trading to introduce its 100% natural insecticide Qcide® to Japan’s $1 billion household pest market, aiming for a late 2026 launch.
Ada Torres
Ada Torres
16 Mar 2026
Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.
Ada Torres
Ada Torres
30 Jan 2026
Bio-Gene Technology Limited has received a $519,500 R&D tax incentive from the Australian government, supporting its development of innovative bio-insecticides targeting insecticide resistance.
Ada Torres
Ada Torres
25 Nov 2025
Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.
Ada Torres
Ada Torres
19 Nov 2025
Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.
Ada Torres
Ada Torres
19 Nov 2025
Contact Energy's October 2025 report reveals rising electricity and gas sales, improved netbacks, and reduced generation costs, supported by robust hydro storage and advancing renewable projects.
Maxwell Dee
Maxwell Dee
18 Nov 2025
Bio-Gene Technology’s natural insecticide Qcide® has earned organic listing status from the US Organic Materials Review Institute, marking a pivotal step for its entry into the organic pest control market.
Ada Torres
Ada Torres
14 Nov 2025
Bio-Gene Technology Limited reports significant progress in Q1 FY26, unveiling new product opportunities and positive efficacy data, alongside securing US Department of Defense grants.
Ada Torres
Ada Torres
31 Oct 2025
Bio-Gene Technology’s novel acaricide Flavocide demonstrated over 90% mortality against Lyme disease-carrying ticks in lab tests presented by Purdue University, highlighting its potential in public health applications.
Ada Torres
Ada Torres
23 Sept 2025
DGL Group reported a 4% revenue increase to $481.5 million in FY25, but underlying profits took a hit due to operational losses and restructuring costs. The company is investing heavily in growth and system integration to drive future efficiency.
Victor Sage
Victor Sage
29 Aug 2025
Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.
Ada Torres
Ada Torres
26 Aug 2025
Bio-Gene Technology Limited has completed the second tranche of its share placement, securing approximately A$2.46 million and issuing unlisted options to investors and its lead manager.
Ada Torres
Ada Torres
21 July 2025